A Study For Using Radiosurgery On Limited Metastases

Completed · Not applicable

Conditions studied: Neoplasms, Metastatic

In brief

The standard therapy in cases such as yours is surgery, radiation therapy, chemotherapy or hormonal therapy alone or in combination. The main purpose of this study is to evaluate whether radiosurgery alone affects your quality and length of life. A second purpose of this study is to determine if the levels of special types of protein (called cytokines) found in the blood are related to your quality of life during your course of treatment and follow-up.

Key facts

Study ID

NCT00178399

Run by

University of Rochester

People needed

128

Starts

2001-04-01

Expected to finish

2007-03-15

Last updated by the study team

2018-10-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• KPS ≥ 70
• Palliative: Disease most likely to be life limiting, is definable, and treatable to a sterilizing dose according to protocol criteria.
• The size of the lesion must be such that it can be safely treated to sterilizing radiation doses according to the rules in the protocol
• Previously treated lesions are not eligible unless the prescribed dose can be safely delivered. Previously enrolled patients can be retreated to new lesions if they still meet protocol requirements.
• Informed consent must be obtained.
• Pregnancy test must be negative for women of child bearing potential.
• Out of state patients are eligible, if communication with the referring physicians is expected to be adequate to address the primary aim. The secondary aim (blood cytokines) is optional for out-of-state patients.

You may not qualify if…

• Technical inability to achieve required dose based on safe dose constraints required for radiosurgery
• Women who are pregnant or nursing..
• Failure to meet inclusion requirements
• Contraindications to radiation.
• Patient should not be eligible for primary disease specific radiosurgical protocols

Where it is running

• University of Rochester Department of Radiation Oncology — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.